4.3 Review

Fluorine-18 and medical imaging: Radiopharmaceuticals for positron emission tomography

Journal

JOURNAL OF FLUORINE CHEMISTRY
Volume 127, Issue 11, Pages 1488-1493

Publisher

ELSEVIER SCIENCE SA
DOI: 10.1016/j.jfluchem.2006.09.015

Keywords

fluorine-18; radiopharmaceuticals; labelled compounds; positron emission tomography

Ask authors/readers for more resources

Fluorine presents among its radioactive isotopes fluorine-18, that decays with a 109 min half-life and a beta(+) emission, allowing external detection of the two coincident gamma photons obtained after annihilation. Production techniques (medical cyclotron), radiochemical reactions for isotope incorporation in radiopharmaceuticals and development of specific detection cameras (positron emission tomographs) allowed development of a vast investigation field in medical imaging. Applications of PET in oncology ([F-18]fluorodeoxyglucose, FDG) largely improved detection and management of cancers; tracer molecules labelled with fluorine-18 also allow fruitful researches in molecular imaging. (c) 2006 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available